MINI FUTURE LONG - IPSEN | Market Closed - Börse Stuttgart 16:45:53 07/06/2024 BST | ||
| 2.26 EUR | 0.00% |
|
| Current month | +10.24% | ||
| 1 month | +53.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 2.26 | 0.00% |
| 06/06/24 | 2.26 | +0.89% |
| 05/06/24 | 2.24 | +4.67% |
| 04/06/24 | 2.14 | -0.93% |
| 03/06/24 | 2.16 | +5.37% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 04:45 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG30BX |
| ISIN | DE000MG30BX4 |
| Date issued | 25/04/2024 |
| Strike | 100 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.37 € |
|---|---|
| Lowest since issue | 1.18 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
122.9
EUR
Average target price
126.4
EUR
Spread / Average Target
+2.85%
- Stock Market
- Certificates
- Certificat